Zynerba Pharmaceuticals, Inc.
http://zynerba.com/
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Zynerba Pharmaceuticals, Inc.
Shionogi Set To Acquire R&D Partner Tetra After Raising Stake
Japanese firm sets stage to acquire US bioventure after it raises stake just ahead of key readout for lead asset.
Finance Watch: Summer Heat Extends To Biopharma IPOs With Nine In July, 45 This Year
Public Company Edition: Nine more biopharma companies launched IPOs in the US in July, bringing the 2018 total to 45 first-time offerings – three more than in all of 2017. Bluebird's $632.5m offering leads recent follow-on public offerings.
Pipeline Watch: Phase III Starts With QPI-1002, Enfortumab Vedotin And ZYN-002
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.
Pipeline Watch: Phase III Starts With VX-445, Reproxalap And AVXS-101
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.
Company Information
- Industry
-
Pharmaceuticals
-
Drug Delivery
- Transdermal
-
Drug Delivery